S, H., P, J., M, F., S, D., S, B., R, A., & A, C. (2020). Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics, 12(9), . https://doi.org/10.3390/pharmaceutics12090810
Chicago Style (17th ed.) CitationS, Hauri, Jakubiak P, Fueth M, Dengl S, Belli S, Alvarez-Sánchez R, and Caruso A. "Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin." Pharmaceutics 12, no. 9 (2020). https://doi.org/10.3390/pharmaceutics12090810.
MLA (9th ed.) CitationS, Hauri, et al. "Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin." Pharmaceutics, vol. 12, no. 9, 2020, https://doi.org/10.3390/pharmaceutics12090810.